205 related articles for article (PubMed ID: 18283272)
1. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.
Hasina R; Whipple ME; Martin LE; Kuo WP; Ohno-Machado L; Lingen MW
Lab Invest; 2008 Apr; 88(4):342-53. PubMed ID: 18283272
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
4. Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF.
Tong M; Lloyd B; Pei P; Mallery SR
J Cell Biochem; 2008 Dec; 105(5):1202-10. PubMed ID: 18802921
[TBL] [Abstract][Full Text] [Related]
5. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
6. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
Masuda M; Ruan HY; Ito A; Nakashima T; Toh S; Wakasaki T; Yasumatsu R; Kutratomi Y; Komune S; Weinstein IB
Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic growth factors in tissue homogenates of HNSCC: expression pattern, prognostic relevance, and interrelationships.
Montag M; Dyckhoff G; Lohr J; Helmke BM; Herrmann E; Plinkert PK; Herold-Mende C
Cancer Sci; 2009 Jul; 100(7):1210-8. PubMed ID: 19385965
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
10. Inherent phenotypic plasticity facilitates progression of head and neck cancer: endotheliod characteristics enable angiogenesis and invasion.
Tong M; Han BB; Holpuch AS; Pei P; He L; Mallery SR
Exp Cell Res; 2013 Apr; 319(7):1028-42. PubMed ID: 23370231
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma.
Oh SH; Kim WY; Lee OH; Kang JH; Woo JK; Kim JH; Glisson B; Lee HY
Cancer Sci; 2012 Jul; 103(7):1259-66. PubMed ID: 22494072
[TBL] [Abstract][Full Text] [Related]
12. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma.
Liss C; Fekete MJ; Hasina R; Lingen MW
Int J Cancer; 2002 Jul; 100(3):283-9. PubMed ID: 12115542
[TBL] [Abstract][Full Text] [Related]
14. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages.
Liss C; Fekete MJ; Hasina R; Lam CD; Lingen MW
Int J Cancer; 2001 Sep; 93(6):781-5. PubMed ID: 11519037
[TBL] [Abstract][Full Text] [Related]
15. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma.
Eisma RJ; Spiro JD; Kreutzer DL
Laryngoscope; 1999 May; 109(5):687-93. PubMed ID: 10334214
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas.
Benefield J; Petruzzelli GJ; Fowler S; Taitz A; Kalkanis J; Young MR
Invasion Metastasis; 1996; 16(6):291-301. PubMed ID: 9371228
[TBL] [Abstract][Full Text] [Related]
17. Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab.
Jouan-Hureaux V; Boura C; Merlin JL; Faivre B
Microvasc Res; 2012 Mar; 83(2):131-7. PubMed ID: 21820450
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
19. Headpin: a serpin with endogenous and exogenous suppression of angiogenesis.
Shellenberger TD; Mazumdar A; Henderson Y; Briggs K; Wang M; Chattopadhyay C; Jayakumar A; Frederick M; Clayman GL
Cancer Res; 2005 Dec; 65(24):11501-9. PubMed ID: 16357159
[TBL] [Abstract][Full Text] [Related]
20. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma.
Marioni G; D'Alessandro E; Giacomelli L; Staffieri A
J Oral Pathol Med; 2010 May; 39(5):361-7. PubMed ID: 20537053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
